Scroll to Top
/ Press Releases & Statements
Press Releases & Statements
IMI Launches Antimicrobial resistance (AMR) projects to revitalise antibiotic development
11 February 2013
Brussels, 11 February 2013 -Today the Innovative Medicines Initiative (link) will launch two new projects through its antimicrobial resistance programme New Drugs for Bad Bugs ...
European Parliament 'Transparency Directive' vote
06 February 2013
European Parliament ‘Transparency Directive’ vote opens way to discussions on procedural guarantees in medicines pricing and reimbursement processes. EFPIA calls on the European Institutions to ...
Healthcare Coalition on Data Protection calls for EU Data Protection Regulation to recognise the essential role of personal data in healthcare
29 January 2013
Brussels– 29 January 2013 - Today the Healthcare Coalition on Data Protection published a joint statement highlighting the role of personal data in delivering high quality, ...
EDCTP and EFPIA sign memorandum of understanding on a Clinical Research Fellowship Scheme for sub-Saharan Africa
24 January 2013
Brussels, 24 January 2013: Today, the European ...
Technology transfer to third countries: how to make it a win-win situation?
23 January 2013
Brussels, 23 January 2013: Yesterday, the MEP Christofer Fjellner (Sweden, EPP) and EFPIA hosted a panel discussion to discuss healthcare technology transfer to third countries. ...
EMA clinical-trials data and transparency workshop 22 November
22 November 2012
London, 22 November 2012: Today’s workshop gave a constructive insight into the different views on the sensitive issue of clinical data transparency. It is impossible to ...
EFPIA: “Working towards responsible transparency”
14 November 2012
Brussels, 14 November 2012: Richard Bergström, speaking today, said: “Medicines should benefit patients. We support measures that enhance the way they are used and enable the ...
Clinical Trials in sub-Saharan African countries
13 November 2012
High-Level EDCTP Conference: African and European policy-makers and EFPIA discuss the EDCTP-II ...
Christopher A. Viehbacher, CEO of Sanofi, designated new President elect of EFPIA
06 November 2012
06.11.2012, Brussels: EFPIA is delighted to announce the designation of Christopher A. Viehbacher, Chief Executive Officer of Sanofi as the new President elect of EFPIA. He ...
EFPIA statement on Healthcare professionals
16 October 2012
Brussels, 16 Ocotober 2012: EFPIA is committed to building trust in how the pharmaceutical industry conducts its business and interacts with key stakeholders. For that reason we ...
Page 18 of 20
Press Releases & Statements
Enabling Technologies for Better Patient Outcomes - Live Streaming
Facts & Figures
Follow us on
Add us on
Check us out on
EFPIA Brussels Office
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
European Biopharmaceutical Enterprises
INNOVATIVE MEDICINES INITIATIVE
Educational Events & Ethical Evaluation
EFPIA 2017 - All rights reserved -
- Design by
Morris & Chapman